Related Articles
DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma
Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma
Overexpression of DEK is an indicator of poor prognosis in patients with gastric adenocarcinoma
DEK is highly expressed in breast cancer and is associated with malignant phenotype and progression
Clinical implications of Ezrin and CD44 co‑expression in breast cancer